Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 8, Issue 9 (2019)

A juvenile onset generalized pyodemodicosis in a Dobermann dog and its therapeutic management

Author(s):
Neeraj Thakur, Chethan GE, Akhilesh, K Mahendran, Ajith Y, Aishwarya Lekshman, CK Gaykwad, UK De and JB Rajesh
Abstract:
In this case report, a juvenile-onset generalized pyodemodicosis in a Dobermann dog and its therapeutic management has been described. A one year old female Dobermann dog was presented with a history of generalized patchy alopecia and pruritus since 2 months. Physical and clinical examination of the animal revealed mild increase in body temperature and presence of generalized erythematous, papular and pustular lesions all over the body. Deep skin scrapings from the lesions revealed cigar shaped Demodex spp. mites. Haematological examination revealed leukocytosis with eosinophilia. Skin swab from the lesions showed presence of Staphylococcus aureus and Pseudomonas aeruginosa isolates and were found to be sensitive for nitrofurantoin, chloramphenicol and cefepime, aztreonam, piperacillin-tazobactam, respectively. Based on history, clinical and laboratory findings, the case was diagnosed as a juvenile onset generalized pyodemodicosis. The dog was treated with topical benzoyl peroxide (2.5% w/v) followed by application of amitraz at 0.025% once in 2 weeks, ivermectin (0.4 mg/kg body weight, po, sid), nitrofurantoin (5 mg/kg body weight, po, bid) and cefepime (40 mg/kg body weight, iv, bid) for 28 days along with supportive therapy consisting omega 3 and 6 fatty acids, tocopheryl acetate and herbal immunostimulant for 60 days. The dog showed improvement in condition after 28 days of therapy and complete recovery was noticed after 90 days.
Pages: 430-433  |  298 Views  80 Downloads


The Pharma Innovation Journal
How to cite this article:
Neeraj Thakur, Chethan GE, Akhilesh, K Mahendran, Ajith Y, Aishwarya Lekshman, CK Gaykwad, UK De, JB Rajesh. A juvenile onset generalized pyodemodicosis in a Dobermann dog and its therapeutic management. Pharma Innovation 2019;8(9):430-433.

Call for book chapter